(48) grouped SSRIs as higher and lower inhibitors dependent on the dissociation constant (Kd) in order to accurately assess for levels of prolactin secreted by the secondary pituitary gland, and found that neither higher nor lower inhibitor of serotonin reuptake increased the risk for breast cancer, which was consistent with our result. The gene discussed is PRL; the disease is breast carcinoma.